Resolution of Inflammation: a New Therapeutic Frontier

Overview

Journal Nat Rev Drug Discov

Specialty Pharmacology

Date 2016 Mar 30

PMID 27020098

Citations 392

Authors

James N Fullerton

Derek W Gilroy

Affiliations

Soon will be listed here.

Abstract

Dysregulated inflammation is a central pathological process in diverse disease states. Traditionally, therapeutic approaches have sought to modulate the pro- or anti-inflammatory limbs of inflammation, with mixed success. However, insight into the pathways by which inflammation is resolved has highlighted novel opportunities to pharmacologically manipulate these processes - a strategy that might represent a complementary (and perhaps even superior) therapeutic approach. This Review discusses the state of the art in the biology of resolution of inflammation, highlighting the opportunities and challenges for translational research in this field.

Citing Articles

Unraveling the role of macrophages in diabetes: Impaired phagocytic function and therapeutic prospects.

Rong B, Jiang H, Zhu W, Yang G, Zhou X, Lyu Z Medicine (Baltimore). 2025; 104(8):e41613.

PMID: 39993124 PMC: 11856964. DOI: 10.1097/MD.0000000000041613.

Arginine metabolism in myeloid cells in health and disease.

Karadima E, Chavakis T, Alexaki V Semin Immunopathol. 2025; 47(1):11.

PMID: 39863828 PMC: 11762783. DOI: 10.1007/s00281-025-01038-9.

Neutrophil heterogeneity and plasticity: unveiling the multifaceted roles in health and disease.

He W, Yan L, Hu D, Hao J, Liou Y, Luo G MedComm (2020). 2025; 6(2):e70063.

PMID: 39845896 PMC: 11751288. DOI: 10.1002/mco2.70063.

Noncanonical role of Golgi-associated macrophage TAZ in chronic inflammation and tumorigenesis.

Park S, Ju S, Lee J, Kim H, Sub Y, Park D Sci Adv. 2025; 11(4):eadq2395.

PMID: 39841821 PMC: 11753377. DOI: 10.1126/sciadv.adq2395.

Bioinspired artificial antioxidases for efficient redox homeostasis and maxillofacial bone regeneration.

Wang T, Bai M, Geng W, Adeli M, Ye L, Cheng C Nat Commun. 2025; 16(1):856.

PMID: 39833195 PMC: 11746915. DOI: 10.1038/s41467-025-56179-0.

References

Sheedy F, Palsson-McDermott E, Hennessy E, Martin C, OLeary J, Ruan Q . Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat Immunol. 2009; 11(2):141-7. DOI: 10.1038/ni.1828. View

Piecyk M, Wax S, Beck A, Kedersha N, Gupta M, Maritim B . TIA-1 is a translational silencer that selectively regulates the expression of TNF-alpha. EMBO J. 2000; 19(15):4154-63. PMC: 306595. DOI: 10.1093/emboj/19.15.4154. View

Seki H, Tani Y, Arita M . Omega-3 PUFA derived anti-inflammatory lipid mediator resolvin E1. Prostaglandins Other Lipid Mediat. 2009; 89(3-4):126-30. DOI: 10.1016/j.prostaglandins.2009.03.002. View

Takao K, Miyakawa T . Genomic responses in mouse models greatly mimic human inflammatory diseases. Proc Natl Acad Sci U S A. 2014; 112(4):1167-72. PMC: 4313832. DOI: 10.1073/pnas.1401965111. View

Chiang N, Fredman G, Backhed F, Oh S, Vickery T, Schmidt B . Infection regulates pro-resolving mediators that lower antibiotic requirements. Nature. 2012; 484(7395):524-8. PMC: 3340015. DOI: 10.1038/nature11042. View

Amulic B, Hayes G . Neutrophil extracellular traps. Curr Biol. 2011; 21(9):R297-8. DOI: 10.1016/j.cub.2011.03.021. View

Berger S, Kasparcova V, Hoffman S, Swift B, Dare L, Schaeffer M . Cutting Edge: RIP1 kinase activity is dispensable for normal development but is a key regulator of inflammation in SHARPIN-deficient mice. J Immunol. 2014; 192(12):5476-80. PMC: 4048763. DOI: 10.4049/jimmunol.1400499. View

Fadok V, Warner M, Bratton D, Henson P . CD36 is required for phagocytosis of apoptotic cells by human macrophages that use either a phosphatidylserine receptor or the vitronectin receptor (alpha v beta 3). J Immunol. 1998; 161(11):6250-7. View

Mocarski E, Kaiser W, Livingston-Rosanoff D, Upton J, Daley-Bauer L . True grit: programmed necrosis in antiviral host defense, inflammation, and immunogenicity. J Immunol. 2014; 192(5):2019-26. PMC: 3934821. DOI: 10.4049/jimmunol.1302426. View

10.

Johnston M, Hay J, Movat H . Kinetics of prostaglandin production in various inflammatory lesions, measured in draining lymph. Am J Pathol. 1979; 95(1):225-38. PMC: 2042292. View

11.

Wilson E, Yamada D, Elsaesser H, Herskovitz J, Deng J, Cheng G . Blockade of chronic type I interferon signaling to control persistent LCMV infection. Science. 2013; 340(6129):202-7. PMC: 3704950. DOI: 10.1126/science.1235208. View

12.

Gyurko R, Van Dyke T . The role of polyunsaturated ω-3 fatty acid eicosapentaenoic acid-derived resolvin E1 (RvE1) in bone preservation. Crit Rev Immunol. 2014; 34(4):347-57. PMC: 4382917. DOI: 10.1615/critrevimmunol.2014009982. View

13.

Chan M, Moore A . Resolution of inflammation in murine autoimmune arthritis is disrupted by cyclooxygenase-2 inhibition and restored by prostaglandin E2-mediated lipoxin A4 production. J Immunol. 2010; 184(11):6418-26. PMC: 3032587. DOI: 10.4049/jimmunol.0903816. View

14.

Rabinovich G, Toscano M . Turning 'sweet' on immunity: galectin-glycan interactions in immune tolerance and inflammation. Nat Rev Immunol. 2009; 9(5):338-52. DOI: 10.1038/nri2536. View

15.

Hopkins J, McConnell I, Pearson J . Lymphocyte traffic through antigen-stimulated lymph nodes. II. Role of Prostaglandin E2 as a mediator of cell shutdown. Immunology. 1981; 42(2):225-31. PMC: 1458077. View

16.

Fredman G, Van Dyke T, Serhan C . Resolvin E1 regulates adenosine diphosphate activation of human platelets. Arterioscler Thromb Vasc Biol. 2010; 30(10):2005-13. PMC: 2982748. DOI: 10.1161/ATVBAHA.110.209908. View

17.

Medeiros A, Serezani C, Lee S, Peters-Golden M . Efferocytosis impairs pulmonary macrophage and lung antibacterial function via PGE2/EP2 signaling. J Exp Med. 2009; 206(1):61-8. PMC: 2626688. DOI: 10.1084/jem.20082058. View

18.

Shyu A, Wilkinson M, van Hoof A . Messenger RNA regulation: to translate or to degrade. EMBO J. 2008; 27(3):471-81. PMC: 2241649. DOI: 10.1038/sj.emboj.7601977. View

19.

Newson J, Stables M, Karra E, Arce-Vargas F, Quezada S, Motwani M . Resolution of acute inflammation bridges the gap between innate and adaptive immunity. Blood. 2014; 124(11):1748-64. PMC: 4383794. DOI: 10.1182/blood-2014-03-562710. View

20.

Taganov K, Boldin M, Chang K, Baltimore D . NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A. 2006; 103(33):12481-6. PMC: 1567904. DOI: 10.1073/pnas.0605298103. View